Standout Papers

Aptamer‐PROTAC Conjugates (APCs) for Tumor‐Specific Targeting in Breast Cancer 2021 2026 2022 2024210
  1. Aptamer‐PROTAC Conjugates (APCs) for Tumor‐Specific Targeting in Breast Cancer (2021)
    Shipeng He, Fei Gao et al. Angewandte Chemie International Edition

Immediate Impact

1 from Science/Nature 63 standout
Sub-graph 1 of 22

Citing Papers

Aptamers as an approach to targeted cancer therapy
2024 Standout
MDM2 Inhibitors for Cancer Therapy: The Past, Present, and Future
2024 Standout
1 intermediate paper

Works of Junhui Ma being referenced

Aptamer‐PROTAC Conjugates (APCs) for Tumor‐Specific Targeting in Breast Cancer
2021 Standout
Homo-PROTAC mediated suicide of MDM2 to treat non-small cell lung cancer
2020

Author Peers

Author Last Decade Papers Cites
Junhui Ma 334 170 85 8 358
Jasper E. Neggers 323 97 44 12 398
J Wang 263 162 51 11 360
Elisabeth Bascans 174 79 140 8 352
Joël P. Charles 260 174 23 8 341
A‐M Faussat 233 156 45 6 410
Shalu Gupta 259 91 18 10 350
Aurora Chinnici 201 146 22 9 314
Antoine Versini 226 98 49 7 380
Archana Dilip 249 81 77 12 321
Brynn T. Kvinlaug 255 89 56 6 346

All Works

Loading papers...

Rankless by CCL
2026